Development of Electroencephalography (EEG) and Magnetoencephalography (MEG) Source Reconstruction With Fast Multipole Method
Launched by WORCESTER POLYTECHNIC INSTITUTE · Jun 20, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to explore new methods for locating brain activity related to different tasks, such as moving fingers, feeling sensations from nerves, and processing speech. Researchers will use a special cap with 256 sensors that can measure brain signals and a new computer program that helps create detailed brain models. By comparing the results from these new techniques with existing data, they hope to improve how we understand where brain activities happen in real-time.
To participate in this study, individuals must be between 18 and 65 years old and have normal hearing and vision. Participants will undergo MRI scans to help create a model of their brain and will complete various tests using the EEG and MEG methods. It’s important to know that certain medical conditions, such as having metal implants or specific neurological issues, may prevent someone from joining the trial. The study has not yet started recruiting participants, but it aims to gather valuable insights that could enhance our understanding of brain function.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age at least 18 and less than 66 years
- • Normal hearing and (corrected) vision
- • Able to understand and give informed consent
- Exclusion Criteria:
- • Cardiac pacemaker or pacemaker wires; neurostimulators; implanted pumps
- • Metal in the body (rods, plates, screws, shrapnel, dentures, IUD) or metallic particles in the eye
- • Surgical clips in the head or previous neurosurgery
- • Any magnetic particles in the body
- • Cochlear implants
- • Prosthetic heart valves
- • History of skull injury or defects
- • Significant claustrophobia; Ménière's disease
- • Pregnancy, breast feeding
- • Neurological or psychiatric diagnoses or medications influencing brain function
- • Current substance abuse (exception: concurrent nicotine use is allowed)
- • Failure to perform the behavioral tasks or psychological evaluation tests
- • Prisoners
About Worcester Polytechnic Institute
Worcester Polytechnic Institute (WPI) is a distinguished private research university renowned for its innovative approach to education and commitment to advancing science and technology. As a clinical trial sponsor, WPI leverages its robust academic resources and interdisciplinary expertise to drive cutting-edge research initiatives, particularly in areas such as biomedical engineering, health sciences, and technology development. With a focus on translating research findings into practical applications, WPI fosters collaborations between academia, industry, and healthcare providers, aiming to enhance patient outcomes and contribute to the advancement of medical knowledge through rigorous clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ilmenau, , Germany
Leipzig, , Germany
Patients applied
Trial Officials
Sergey N Makaroff, PhD
Principal Investigator
Worcester Polytechnic Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported